In addition, our comprehensive evaluation of LYPD3 expression and phenotypic traits across a spectrum of cell lines has indicated the plausible tumor-suppressive nature of LYPD3 in HNSCC cells. This evidence concerns the gene LYPD3 and neoplasm.